Dutasteride and side effects: Separating fact from fear 

DoktorABC editorial team

Accurate, up-to-date health information written by our editorial team and reviewed by UK-registered prescribers.

How common are dutasteride side effects?

Dutasteride is generally well tolerated at the low doses used for hair loss, though side effects do occur in a meaningful proportion of men and should be understood before starting treatment. 

Adverse events for dutasteride were predominantly sexual, with an incidence rate ranging from 2% to 16% across clinical studies, compared to 8% to 13.4% for finasteride. The most common sexual adverse events are altered libido (primarily decreased libido), followed by impotence, ejaculation disorders, breast enlargement, and breast tenderness. 

The range in reported incidence reflects differences between studies, doses, and populations. It is also worth noting that adverse event rates in placebo arms of these trials are not negligible, reflecting the background rate of sexual dysfunction in the study populations. The net drug-attributable effect is therefore somewhat lower than the headline figures suggest.

Sexual side effects: what the evidence shows

The most common sexual adverse side effects with dutasteride are decreased libido, impotence (erectile dysfunction), and ejaculation disorders. Most sexual adverse events occur in the early stages of treatment, with a decrease in incidence in the later stages. In a four-year phase III clinical trial of 0.5 mg oral dutasteride daily, there was an overall decreasing trend in the incidence of the most common sexual adverse events: decreased libido was reported in 3.7% of patients in the first year, 0.6% in the second year, 0.4% in the third year, and 0.1% in the fourth year.

This pattern suggests that for most men who experience sexual side effects, they are most pronounced in the early months of treatment and reduce over time with continued use. This is consistent with what is observed clinically, and the data does not support a conclusion that side effects inevitably worsen with duration.

However, it is important not to dismiss these side effects. They are real, they affect a meaningful proportion of men, and some find them significant enough to discontinue treatment.

Are dutasteride side effects permanent?

The large majority of men who experience sexual side effects on dutasteride find they resolve after stopping treatment. Sexual adverse events with dutasteride are usually mild to moderate and may resolve during treatment or after discontinuation of the drug. 

However, a small number of men report persistent sexual side effects after stopping 5-alpha reductase inhibitors, a cluster of symptoms sometimes referred to in the context of post-finasteride syndrome (PFS). The equivalent phenomenon has been discussed in relation to dutasteride as well, though the evidence base is less developed than for finasteride.

The MHRA conducted a safety review of finasteride in 2024, which acknowledged reports of persistent sexual and psychological side effects in a subset of users while noting the difficulty of establishing causation. Similar considerations apply to dutasteride.

For most men, side effects resolve upon stopping the medication. For a small minority, they may persist. This risk, while rare, is real and should be discussed with your prescriber before starting treatment.

Mental health and mood-related side effects

Mood changes, depression, and in rare cases suicidal ideation have been reported in association with 5-alpha reductase inhibitors including dutasteride. Dutasteride is associated with less but elevated incidence of side effects such as sexual dysfunction, decreased libido, and in some cases depression, compared to placebo.

The biological plausibility for mood effects exists: 5-alpha reductase inhibitors reduce neurosteroids derived from testosterone and progesterone that modulate GABA receptors and other central nervous system pathways. However, establishing causation from observational data in populations where mood disorders are common is difficult.

Breast tissue changes (gynaecomastia)

Breast enlargement and breast tenderness are listed as known adverse events of dutasteride and are related to the shift in the testosterone-to-oestrogen ratio that occurs when DHT production is suppressed. Breast enlargement and breast tenderness are among the most common sexual and hormonal adverse events reported with dutasteride. 

These effects are typically mild and resolve on stopping treatment in most cases. However, in rare cases, breast tissue changes may not fully reverse after discontinuation. Any new breast lump, nipple discharge, or significant breast enlargement should be assessed by a GP regardless of whether you are taking dutasteride.

Topical dutasteride side effects

Topical dutasteride is an off-label formulation applied directly to the scalp rather than taken orally. It is not MHRA-licensed in any form and is available only through compounding pharmacies on private prescription.

The theoretical advantage of topical application is reduced systemic absorption, which may lower the risk of systemic side effects including sexual dysfunction. A 2025 Phase II trial of topical dutasteride solution found minimal systemic hormone changes across the topical arms, and a real-world study of 541 patients receiving dutasteride via mesotherapy reported no sexual adverse events.

However, the evidence base for topical dutasteride is considerably smaller than for the oral form, and the absence of reported sexual adverse events in these studies should not be taken as a guarantee they cannot occur. Any dutasteride that enters the bloodstream has the potential to affect hormone-sensitive tissues. 

Hair loss dosing vs Benign Prostatic Hyperplasia (BPH) dosing, and why it matters

The licensed dose for BPH is 0.5 mg daily. Many prescribers use lower doses for androgenetic alopecia, typically in the range of 0.1 mg to 0.5 mg, though practice varies and there is no formally established consensus dose for hair loss in the UK.

A 2025 Phase III clinical trial found that 0.2 mg dutasteride daily led to greater hair growth improvement compared to placebo at weeks 12 and 24, suggesting that doses below the standard 0.5 mg BPH dose can produce clinically meaningful hair loss benefit.

The relevance to side effects is significant: lower doses suppress DHT less completely than 0.5 mg, which may produce a more favourable side effect profile while still delivering meaningful hair growth benefit. This dose-response relationship for both efficacy and side effects is an important part of the prescriber conversation.

Do dutasteride side effects go away?

For most men, yes. Sexual side effects are most commonly reported in the first few months of treatment and tend to reduce in frequency and severity over time for those who continue. For those who stop, the majority experience resolution of side effects as dutasteride clears the system.

Dutasteride has a long half-life of approximately three to five weeks, meaning it clears more slowly from the body than finasteride. This means that after stopping, the effects of the drug persist for longer before full clearance occurs, and resolution of side effects may take several months rather than weeks.

Dutasteride vs finasteride: Side effects compared

Both dutasteride and finasteride are 5-alpha reductase inhibitors and share broadly similar side effect profiles. The key pharmacological difference is that dutasteride inhibits both type I and type II 5-alpha reductase, making it more potent than finasteride, which inhibits only type II. The table below summarises the key differences in side effect profile based on available clinical data.

When to contact a prescriber about side effects

Contact your prescriber if you experience:

• Reduced libido, erectile dysfunction, or ejaculation changes that affect your quality of life
• Mood changes, depression, or anxiety that feel linked to starting treatment
• Breast enlargement, breast tenderness, or any breast lump
• Any side effect that significantly affects your daily life

Seek medical attention promptly if you experience:

• Thoughts of self-harm or suicide
• Any new breast lump or nipple discharge
• Severe or rapidly worsening symptoms of any kind

Report suspected side effects to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Final thoughts

Dutasteride is an effective treatment for androgenetic alopecia with a side effect profile that is real but manageable for most men who use it under appropriate medical supervision. The sexual side effects that concern most people are less common than many fear, tend to reduce over time, and resolve in the majority of men who stop treatment.

What matters most is informed consent: understanding the risks before starting, knowing what to monitor for, and having a prescriber who can support you through any side effects that do arise. Dutasteride should never be sourced from unregulated channels, and its off-label status for hair loss makes clinical oversight particularly important.

FAQ

The DoktorABC medical advisory board

Dr. Roland Ruiken

Medical advisor, Norway

Dr. Viktor Simunovic

Medical advisor, Croatia

To the medical advisory board